powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1134652266
Sai Bhuvanagiri
M.D.
Endocrinology
Modesto,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
QUALITY · MIPS · 2024
Final MIPS score
85.6
Quality
64.4
Cost
72.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 050067
Hospital
CCN 050179
Hospital
CCN 050444
Hospital
CCN 050464
Hospital
CCN 050557
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
4,053
Beneficiaries
—
Total drug cost
$2.1M
Distinct drugs
38
Brand share
65.5%
Top prescribed drugs
Semaglutide
508 claims
Levothyroxine Sodium
365 claims
Metformin Hcl
281 claims
Insulin Glargine,hum.Rec.Anlog
279 claims
Empagliflozin
255 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
673
Unique beneficiaries
—
Total services
2,620
Distinct HCPCS
8
Medicare payment
$95K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — above median (cohort median 1,164).
